Browse by Journals
Number of items: 9.
B
BEST, David
(2016).
Developing strengths-based recovery systems through community connections.
Addiction.
(In Press)
[Article]
BEST, David
(2016).
Why the mechanisms of 12-Step behaviour change should matter to clinicians.
Addiction, 112 (6), 938-939.
[Article]
BROWN, Kyle G., REIDY, John, WEIGHALL, Anna R. and ARDEN, Madelynne
(2013).
Graphic imagery is not sufficient for increased attention to cigarette warnings: the role of text captions.
Addiction, 108 (4), 820-825.
[Article]
G
GOSSOP, M., BEST, David, MARSDEN, J. and STRANG, J.
(1997).
Test-retest reliability of the Severity of Dependence Scale [1].
Addiction, 92 (3), p. 353.
[Article]
H
HALL, Kate, STAIGER, Petra K., SIMPSON, Angela, BEST, David and LUBMAN, Dan I.
(2015).
After 30 years of dissemination, have we achieved sustained practice change in motivational interviewing?
Addiction, 111 (7), 1144-1150.
[Article]
M
MARSDEN, J, GOSSOP, M., STEWART, D., BEST, David, FARRELL, M., LEHMANN, P., EDWARDS, C and STRANG, J.
(1998).
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome.
Addiction, 93 (12), 1857-1867.
[Article]
S
STRANG, John, MANNING, Victoria, MAYET, Soraya, BEST, David, TITHERINGTON, Emily, SANTANA, Laura, OFFOR, Elizabeth and SEMMLER, Claudia
(2008).
Overdose training and take-home naloxone for opiate users : prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.
Addiction, 103 (10), 1648-1657.
[Article]
STRANG, John, MANNING, Victoria, MAYET, Soraya, RIDGE, Gayle, BEST, David and SHERIDAN, Janie
(2007).
Does prescribing for opiate addiction change after national guidelines? : methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
Addiction, 102 (5), 761-770.
[Article]
STRANG, John, POWIS, Beverly, BEST, David, VINGOE, Louisa, GRIFFITHS, Paul, TAYLOR, Colin, WELCH, Sarah and GOSSOP, Michael
(1999).
Preventing opiate overdose fatalities with take-home naloxone : pre-launch study of possible impact and acceptability.
Addiction, 94 (2), 199-204.
[Article]